In this episode of SciBud, we dive into groundbreaking research that melds biotechnology with artificial intelligence to revolutionize cancer diagnosis at the molecular level. Join Rowan as we unpack a study exploring the innovative NDAM platform, which uses machine learning, DNA origami, and atomic force microscopy to detect cancer-related mutations with remarkable precision. Focusing on elusive cancers like pancreatic and colorectal, this method enables real-time observation of individual molecules, offering unprecedented insight into genetic markers such as KRAS and p53. While the approach presents exciting possibilities for early and accurate diagnosis that could enhance patient outcomes, we also discuss its limitations and areas for further research. Tune in to discover how this cutting-edge technology may transform the landscape of molecular diagnostics and improve treatment strategies in the fight against cancer! Link to episode page with article citation: www.scibud.media/podcast/season/2026/episode/328
Fler avsnitt av SciBud: Emerging Discoveries from Bioimaging
Visa alla avsnitt av SciBud: Emerging Discoveries from BioimagingSciBud: Emerging Discoveries from Bioimaging med Galo Garcia finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
